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Abstract
Background: DNA methylation, which mainly occurs at CpG dinucleotides, is a dynamic epigenetic regulation
mechanism in most eukaryotic genomes. It is already known that methylated CpG dinucleotides can lead to a high
rate of C to T mutation at these sites. However, less is known about whether and how the methylation level
causes a different mutation rate, especially at the single-base resolution.
Results: In this study, we used genome-wide single-base resolution methylation data to perform a comprehensive
analysis of the mutation rate of methylated cytosines from human embryonic stem cell. Through the analysis of
the density of single nucleotide polymorphisms, we first confirmed that the mutation rate in methylated CpG sites
is greater than that in unmethylated CpG sites. Then, we showed that among methylated CpG sites, the mutation
rate is markedly increased in low-intermediately (20-40% methylation level) to intermediately methylated CpG sites
(40-60% methylation level) of the human genome. This mutation pattern was observed regardless of DNA strand
direction and the sequence coverage over the site on which the methylation level was calculated. Moreover, this
highly non-random mutation pattern was found more apparent in intergenic and intronic regions than in
promoter regions and CpG islands. Our investigation suggested this pattern appears primarily in autosomes rather
than sex chromosomes. Further analysis based on human-chimpanzee divergence confirmed these observations.
Finally, we observed a significant correlation between the methylation level and cytosine allele frequency.
Conclusions: Our results showed a high mutation rate in low-intermediately to intermediately methylated CpG
sites at different scales, from the categorized genomic region, whole chromosome, to the whole genome level,
thereby providing the first supporting evidence of mutation rate variation at human methylated CpG sites using
the genome-wide sing-base resolution methylation data.
Background
Germline mutation can profoundly affect genetic varia-
tion within populations and divergence between species.
The identification of factors that modulate mutation
rates in germ cells, particularly in humans, has been a
long-standing scientific pursuit [1]. Several factors are
thought to be related to mutation rate, including DNA
replication timing [2], genetic recombination [3], and
categorized genomic regions [4]. The mutation rate is
also known to vary throughout the genome in a contex-
tual fashion [1], the most well-studied example being the
influence of CpG dinucleotides in mammalian genomes.
CpGs are generally methylated in mammalian genomes,
and since the deamination rates of methylated cytosine is
2.0 to 3.2 fold more than unmethylated cytosine [5], it
leads to a 10- to 50-fold higher transition rate of methy-
lated CpG to TpG than other transitional changes [6,7].
This rate difference in turn causes the suppression of
CpG sites in the mammalian genomes [8,9]. However,
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whether and how a variation in methylation level causes
the variation in the high mutation rate is still unknown.
Based on the analysis of single nucleotide polymorph-
isms (SNPs), Fryxell and Moon [10] have concluded that
methylation-dependent transition rates are exponentially
dependent on local GC content. Our re-examined studies
further indicated that these methylation-dependent tran-
sition rates in the human genome were dependent on
both the local sequence length and the genomic region
[7]. In a recent study of CpG mutability in intronic
regions of the human genome [11], CpG substitution
rates were observed to be significantly correlated with
the extent of methylation level. In the same study, they
also found that the CpG substitute rate is positively cor-
related with non-CpG divergence and negatively corre-
lated with GC content [11]. However, their conclusion is
based on MeDIP methylation data, which is calculated in
a low resolution for a 100-bp (base pair) window size
[12]. Moreover, although their results showed that the
methylation level affected the mutation rate, their investi-
gation limited in the intronic regions only, and the muta-
tion pattern in other genomic regions remained unclear.
More recently, next-generation sequencing has pro-
vided single-base resolution DNA methylome in the
human genome [13], thus making more comprehensive
analysis possible [14-17]. The availability of whole-gen-
ome methylation maps with single-nucleotide resolution
provides an opportunity to refine studies pertaining to
CpG mutation rate variation. Compared with array data,
the advantage of sequencing data can not only be used to
estimate methylation broadness but also be used to ana-
lyze methylation deepness for each single base [17].
Here, we used genome-wide, single-base-resolution
maps of methylation data [13] in human embryonic stem
cell line (H1) to perform an extensive investigation of the
correlation between the level of cytosine methylation and
CpG mutability of the human genome. In addition to the
methylation on CpG sites, we also examined the effect of
methylation level on non-CpG sites (e.g., CHG/CHH,
where H = A, C, or T) sites. We observed that among
methylated CpG sites, the mutation rate, as reflected by
the human SNP density, is markedly increased in low-
intermediately to intermediately methylated CpG sites at
different scales, from the categorized genomic region,
whole chromosome, to the whole genome level. This
observation was also confirmed by human-chimpanzee
divergence data. Finally, we found a significant correla-
tion between methylation level and cytosine allele
frequency in the human genome.
Materials and methods
DNA methylation profile in the human genome
The single-base resolution DNA methylation data were
derived from Lister et al. [13], including whole genome
bisulfite sequencing data for two human cell lines: H1
human embryonic stem cell and IMR90 fetal lung fibro-
blast. We removed all methylcytosines that could not be
mapped to reference CpG sites (NCBI Build 36) in our
analysis. For the remaining mapped methylcytosines, we
used methylation deepness [17] to evaluate the methyla-
tion level in the CpG site, which represents the extent of
the methylation level of the cytosines based on the ratio
of the number of reads having methylated cytosine over
the total number of reads mapped to each reference CpG
site. CpG sites can be classified as methylated CpG sites
if there is at least one read covering methylated cytosine
(methylation level > 0%). Otherwise, they are classified as
the unmethylated CpG sites, i.e. methylation level = 0%.
Methylated CpG sites are further categorized into five
groups of increasing methylation levels: lowly methylated
(less than or equal to 20%), low-intermediately methy-
lated (20-40%), intermediately methylated (40-60%),
high-intermediately methylated (60-80%), and highly
methylated (greater than 80%).
Genome sequence and annotation
The human reference genome sequence (Build 36) was
downloaded from NCBI website [18]. Genomic annota-
tions, including the start and end positions of genes and
exons, were defined based on the ENSEMBL database
[19]. Promoter was defined as an interval of -1500 to
+500 bp around the transcriptional start site (TSS) as pre-
viously described[20]. A genic region was defined as the
transcribed region from the start to the end of transcrip-
tion sites. An intergenic region was defined as a region in
which no known gene was annotated. Similarly, an intro-
nic region was defined as the region in which no known
exon was annotated [20]. According to our previous com-
parisons [21,22], we used Takai and Jones’ algorithm [23]
to identify CpG islands (hereafter, we abbreviated as
CGIs): length ≥ 500 bp, GC content ≥ 55%, and CpG
observed/expected (O/E) ratio ≥ 0.65.
Estimation of mutation rate
To estimate the mutation rates, we followed the approach
in previous studies [2,24] to use the data from both
human SNP density and human-chimpanzee divergence.
We downloaded the human SNPs data from the NCBI
dbSNP database (build 130) website [18] and only consid-
ered the validated reference SNPs [4]. A total of
16,969,034 validated reference SNPs were available (with
reference SNP ID and reference annotation). Among
them, 12,236,967 were bi-allelic and uniquely mapped in
the genome, which were used for our further analysis. The
SNP density is estimated by computing the total number
of C/A, C/G, and C/T SNPs over the total number of cyto-
sine bases in the human genome.
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We estimated the divergence of CpGs between the
human and chimpanzee genomes based on the human
and chimpanzee alignment. We downloaded alignments of
the hg18 version of the human genome and PanTro2 ver-
sion of the chimpanzee genome from UCSC Genome
Browser [25]. The divergence is calculated as the propor-
tion of different sites between human and chimpanzee
genomes among the total sites that could be aligned
between human and chimpanzee genomes.
Human allele data
For human allele frequency data, we used CEU (Utah
residents with Northern and Western European ancestry
from the CEPH collection) population data that we
downloaded from UCSC Genome Browser [25]. This
data set also includes chimpanzee nucleotide information
for each allele set when available; thus, we could deter-
mine which allele was the ancestral one based on our
previous study[4].
Results and discussion
Mutation rate in CpG sites with different methylation
level
To investigate the mutation rates of CpG sites with differ-
ent methylation levels, we analyzed the SNP density in the
human genome, which represented recent mutations in
the human population [2]. We mapped C/A, C/G, and C/
T SNPs to CpG sites regardless of their methylation levels.
For CpG sites within the same methylation level group, we
estimated the mutation rate by computing the number of
these SNPs (C/A, C/G, and C/T) over the total number of
cytosine bases in the human genome. Since methylated
CpGs are highly mutable, one would expect to observe
that CpGs with high levels of methylation are more likely
to mutate. Indeed, we found that the unmethylated CpGs
had a lower mutation rate (1.08%) compared with methy-
lated CpGs (3.55%) (Figure 1). Here, mutation rate was
measured by the SNP density [2]. The mutation rate in
methylated CpGs was also slightly higher than the total
CpGs (3.16%) in the human genome, since more than 80%
of CpGs are methylated in the human genome [13].
Among the five CpG methylation level groups, we
observed a trend that when CpG methylation level
increased, the proportion of CpG sites in that group
increased as well (the classification of methylation level
was described in the Materials and Methods section). Spe-
cifically, the number of CpG sites with lowly, low-interme-
diately, intermediately, high-intermediately and highly
methylated levels was 168,353 (0.7%), 511,909 (2.2%),
1,384,329 (5.9%), 4,557,575 (19.5%), and 16,788,938
(71.7%), respectively. Interestingly, when we compared
mutation rate in different groups of methylated CpGs, we
found that CpG sites with low-intermediate (20-40%) and
intermediate (40-60%) levels of methylation actually had a
Figure 1 The mutation rates for all CpG sites, methylated CpG sites and unmethylated CpG sites. The methylated CpG sites are further
categorized into five groups according to their methylation levels. The X-axis includes CpG sites with different methylation levels (Total_CpG:
total CpG; mCpG: methylated CpG; H_mCpG: highly methylated CpG (> 80%); HI_mCpG: high-intermediately methylated CpG (60-80%); I_mCpG:
intermediately methylated CpG (40-60%); LI_mCpG: low-intermediately methylated CpG (20-40%); L_mCpG: lowly methylated CpG (≤ 20%);
unCpG: unmethlated CpG). The Y-axis is the mutation rate that was calculated as the SNP density at CpG sites.
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much higher mutation rate compared with lowly (≤ 20%),
high-intermediate (60-80%) and highly methylated CpGs
(> 80% methylation). For example, low-intermediately
methylated CpG sites had a high mutation rate that could
reach up to 11.75%, whereas highly methylated and lowly
methylated CpGs only had a mutation rate of 2.93% and
6.32%, respectively.
We compared the mutation rate of methylated CpG
sites in H1 and IMR90 cell lines (see additional file 1). We
found that the mutation pattern in IMR90 cell line is over-
all similar to that in H1 cell line, though it is not as evident
as in H1 cell line. One possible reason is that the H1 cell
line is derived from human embryonic stem cells while the
IMR90 cell line is originated from human fetal lung fibro-
blasts. It has been suggested that stem cells have more
opportunity to accumulate mutations compared with
mature cells [26]. Therefore, the mutation pattern shows
stronger difference in CpG sites with 20-60% methylation
level in H1 cell line than IMR90 cell line.
To examine whether the strand bias affected the muta-
tion pattern, we further analyzed the data in the minus
strand to compensate for the plus strand pattern observed
above. We observed the same pattern when the methyla-
tion data of the minus strand was analyzed (see additional
file 2). This observation is consistent with the previous
report that the DNA methylation levels of two strands in
any given genomic region are highly symmetric [13].
The methylation profile we used in this study was gener-
ated by single-base resolution bisulfite sequencing technol-
ogy. According to this technology, the more reads that
cover the CpG site, the higher confidence we can obtain
regarding the base it detects. Therefore, we checked
whether our observation was affected by the read cover-
age. We found an overall similar pattern regardless of the
cut-off values of the coverage we used (see additional file
3). Particularly for CpG sites with low-intermediate and
intermediate levels of methylation, we found an even
higher mutation rate with higher coverage. For example,
we observed that the mutation rate increased to 15.26%
when intermediately methylated CpG sites were covered
by at least 10 sequencing reads compared with 11.00%
when they were covered by at least 5 reads. This finding
suggests that our observation that CpG sites with low-
intermediate and intermediate levels of methylation actu-
ally had a much higher mutation rate is not affected by the
sequence coverage of methylated sites. With the increased
coverage, our observations could be even more apparent.
Mutation rate of methylated CpG site in the categorized
genomic regions
We previously observed the correlation of the rate of
germ line mutation with the categorized genomic regions
[4]. Here, we further investigated the mutation rates of
methylated CpG sites in categorized genomic regions.
The results (see Figure 2) are summarized in the follow-
ing four points. First, we observed a higher distribution
of SNP density in intergenic regions compared with
other regions of methylated CpG sites at all methylation
levels. Here, intergenic regions are defined as regions
without any gene annotation. This result was expected,
as most mutations in intergenic regions are not subject
to selection, and thus, display a higher mutation rate.
Second, compared with intergenic regions, the mutation
rates in other genomic regions (e.g., intronic regions,
exonic regions, promoter regions, and CGIs) were mod-
erately lower than those of the whole genome regardless
of their methylation level. Third, for those CpG sites
located in the CGIs or promoter regions, the mutation
rate was overall very low, but consistent, regardless of the
methylation level. This trend is likely due to the lack of
methylation and the suppression of methylcytosine dea-
mination in CGIs and promoter regions [4]. Finally, the
CpG sites in intergenic regions and intronic regions
showed a higher mutation rate with low-intermediate
and intermediate levels of methylation.
Mutation rate of methylated CpG site among
chromosomes
We further examined the mutation rate pattern in
human chromosomes (Figure 3). It is already known that
the mutation rate varies among chromosomes. Within
chromosomes, we observed that CpG sites with low-
intermediate and intermediate levels of methylation had
a higher mutation rate in all autosomes compared with
that of other methylated CpG sites. Furthermore, there
were differences in the mutation rate among autosomes.
For example, methylated CpG sites in chromosomes 4,
13, 18, and 21 had a higher mutation rate compared with
that in other autosomes. We noticed that these four
autosomes have overall low gene densities; thus, we
further analyzed the relationship between the mutation
rate and gene density. We found a negative correlation
between the mutation rate and gene density (see addi-
tional file 4), and this result further supports the higher
mutation rate at the intergenic regions.
A similar mutation pattern could not be observed in the
X chromosome due to an overall low mutation rate in this
sex chromosome. We only found a slightly higher muta-
tion rate in the CpG sites with a lowly methylated level
(0-20%) (Figure 3).
Mutation rate of non-CpG methylated cytosines
The H1 cell line has abundant non-CpG methylation
(mCHG and mCHH, where H = A, C or T) that accounted
for nearly 25% of all methylated cytosines. Therefore, we
investigated the mutation rate in these methylated non-
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CpG sites. A summary of the mutation rate from mCHG
and mCHH sites was provided in additional file 5.
We found that the mutation rates in methylated non-CpG
sites were low across the different methylation levels in
these sites (0.38-0.42% for mCHG, and 0.39-0.54% for
mCHH); thus, we did not observe the pattern as in the
methylated CpG sites.
Sequence divergence at methylated CpG sites
To further confirm our observations based on SNP den-
sity, we used human-chimpanzee sequence divergence to
infer the mutation rate (Figure 4). Again, we found the
highly methylated CpG sites (9.94%) had larger divergence
than lowly methylated CpG sites (7.23%). More interest-
ingly, the divergence of CpGs with methylation levels of
20-40% and 40-60% was 10.66% and 10.49%, respectively.
This divergence was higher than the divergence of CpGs
with methylation levels of 60-80% and 80-100%, which is
consistent with our SNP density data. To exclude the pos-
sible effects of selection on functional regions, we further
investigated the divergence in intergenic regions. A similar,
but even more evident, pattern was observed (see addi-
tional file 6).
Allele frequency at methylated CpG sites
Using CEU population data from the HapMap Project
(release 21), we assigned an allele frequency for each
SNP. After mapping C/A, C/G, and C/T SNPs to methy-
lated CpG sites, the ancestor allele of a methylated cyto-
sine site could be inferred by comparing a SNP with its
chimpanzee ancestral allele based on our previous
method [4]. There were 250,541 methylated CpG sites
with inferred ancestor alleles. By calculating the correla-
tion between the methylation level and allele frequency
in these methylated CpG sites, we found a significant
Pearson correlation between methylation level and cyto-
sine allele frequency (r = 0.426, P < 2.2E-16) as compared
to the correlation between methylation level and major
allele frequency (r = 0.198, P < 2.2E-16) or the correlation
between methylation level and ancestor allele frequency
(r = 0.359, P < 2.2E-16). We further binned CpG sites
into five classes according to cytosine allele frequency
Figure 2 The mutation rates for methylated CpG sites in the human genome and categorized genomic regions. The X-axis includes CpG
sites with different methylation levels (H_mCpG: highly methylated CpG (> 80%); HI_mCpG: high-intermediately methylated CpG (60-80%); I_mCpG:
intermediately methylated CpG (40-60%); LI_mCpG: low-intermediately methylated CpG (20-40%); L_mCpG: lowly methylated CpG (≤ 20%)). The Y-axis
is the mutation rate that was calculated as the density of SNPs at CpG sites.
Xia et al. BMC Genomics 2012, 13(Suppl 8):S7
http://www.biomedcentral.com/1471-2164/13/S8/S7
Page 5 of 9
Figure 3 Comparison of the mutation rates at methylated CpG sites in the human genome and its chromosomes. Refer to Figure 1
legend for interpretation of abbreviations.
Figure 4 Human-chimpanzee divergence in CpG sites categorized by different methylation level. Refer to Figure 1 legend for
interpretation of abbreviations.
Xia et al. BMC Genomics 2012, 13(Suppl 8):S7
http://www.biomedcentral.com/1471-2164/13/S8/S7
Page 6 of 9
and carried out a regression analysis using methylaton
level data. The methylation level associated with the cyto-
sine allele frequency displayed a strong linear dependence
with a correlation coefficient r = 0.977 (Figure 5).
To further test whether the methyltion level depends
on the allele frequency information, we examined the
methylation level in CpG sites with different allele fre-
quencies. First, we compared the methylation level when
the major allele is cytosine with that when it is not. The
methylation level was higher with cytosine as the major
allele than with other bases as the major allele (0.798 vs.
0.605, P < 2.2E-16). The methylation level was also higher
when the ancestral allele is cytosine than other bases
(0.792 vs. 0.703, P < 2.2E-16). The directionality observed
in these values is consistent with the fact that deamina-
tion of methylated cytosine results in C ® T mutations
that likely remain unrepaired and, therefore, become
polymorphisms. For those alleles with cytosine as the
ancestral allele, we further categorized them as to
whether their current major allele is cytosine or other
base. We found that for those alleles with cytosine as the
ancestor, their methylation level significantly increased
when cytosine became the current major allele relative to
another base as the current major allele (0.810 vs. 0.610,
P < 2.2E-16). The increased methylation level of CpG
sites with cytosine as both the ancestral allele and the
current major allele further suggest that these methylated
CpGs are representative of hypermutable sites. Taking
together, these results indicated that the subset of methy-
lated CpGs in the derived allele dataset is not a random
subset of the genome. The observed overrepresentation
of methylated CpGs in all data sets suggests that the
methylated CpGs variable is indicative of the previously
known hypermutability of methylated cytosines.
Conclusion
Previous studies have suggested that methylated CpG
sites correlate strongly to a high rate of mutation. How-
ever, whether and how the higher methylation level
causes the higher mutation rate is largely unknown. Our
analysis showed that CpG sites with low-intermediate to
intermediate levels of methylation (20-60%) actually had
a much higher mutation rate as reflected in recent
human nucleotide diversity as compared with CpG sites
with other methylation levels at different scales, including
the categorized genomic regions, whole chromosome,
and the whole genome. Consistently, we observed a simi-
lar pattern by using human-chimpanzee divergence data.
We further examined variation in the mutation rate
among chromosomes. Within autosomal chromosomes,
we observed that CpG sites with low-intermediate and
intermediate levels of methylation had a higher mutation
rate compared with CpG sites with other methylation
levels. We found that autosomes with low gene density
Figure 5 The correlation between methylation level and cytosine allele frequency. The X-axis includes five classes of CpG sites defined on
the basis of their cytosine allele frequency. The Y-axis is the methylation level that was computed as the number of methylated reads over the
total number of reads mapped to each cytosine base. The correlation coefficient (r2) is shown on the plot.
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tend to have an overall higher mutation rate. Because of
male-driven evolution [27] in humans, mutation rates are
typically highest on the Y chromosome, intermediate on
autosomes, and lowest on the X chromosome. Indeed, the
mutation rate was higher on the CpG sites in autosomes
than that in the X chromosome. However, we could not
estimate the mutation rate in the Y chromosome due to
the overall low quality data. Further investigation is neces-
sary when high quality data in this sex chromosome is
available.
In summary, our study found a significant correlation
between the extent of germ line methylation and the
mutation rate at human CpG sites. Specifically, we
found that there is a high mutation rate in low-interme-
diately to intermediately methylated CpG sites at differ-
ent scales, from the categorized genomic region, whole
chromosome, to the whole genome level. Mutation rate
has been found to be correlated with proximal DNA
methylation patterns [11,28], local GC content[10], local
sequence lengths and genomic regions[7], local or regio-
nal nucleotide composition, crossover rate, distance to
telomeres, chromatin compaction [24], as well as the
replication timing [2]. Our analysis provides the first
supportive evidence regarding the mutation rate varia-
tion at human methylated CpG sites using genome-wide
single base resolution methylation data. However,
further integrative investigation of genetic factors on the
mutation rate and methylation level is warranted.
Finally, we have shown that there is a significant corre-
lation between methylation level and cytosine allele fre-
quency in the human genome.
Additional material
Additional file 1: The mutation rates at CpG sites inH1 and IMR90
cell lines. Refer to Figure 1 legend for interpretation of abbreviation.
Additional file 2: The mutation rates for all CpG sites, methylated
CpG sites and unmethylated CpG sites in different DNA strands.
Refer to Figure 1 legend for interpretation of abbreviation.
Additional file 3: The mutation rates for methylated CpG sites that
are covered by different levels of sequencing reads. Refer to Figure 1
legend for interpretation of abbreviation.
Additional file 4: The correlation between mutation rate and gene
density for methylated CpG sites at the chromosome level. Each
chromosome is plotted as a dot with its gene density per megabase and
SNP density on the X and Y axis, respectively. The correlation coefficient
(r2) is shown on the plot.
Additional file 5: The mutation rates for CHG and CHH sites with
different methylation levels. The X-axis includes CHH and CHG sites
with different methylation levels (mC: methylated site; H_mC: highly
methylated site (> 80%); HI_mC: high-intermediately methylated site (60-
80%); I_mC: intermediately methylated site (40-60%); LI_mC: low-
intermediately methylated site (20-40%); L_mC: lowly methylated site (≤
20%)). The Y-axis is the mutation rate that was calculated as the density
of SNPs at CHH and CHG sites.
Additional file 6: Human-chimpanzee divergence for methylated
CpG sites in the human genome and intergenic regions. Refer to
Figure 1 legend for interpretation of abbreviation.
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